Cingulate Earnings Estimate
| CING Stock | USD 6.34 0.25 4.11% |
Cingulate | Build AI portfolio with Cingulate Stock |
Cingulate Earnings Estimation Breakdown
The calculation of Cingulate's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cingulate is estimated to be -2.95625 with the future projection ranging from a low of -8.82 to a high of -0.9125. Please be aware that this consensus of annual earnings estimates for Cingulate is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-8.82 Lowest | Expected EPS | -0.91 Highest |
Cingulate Earnings Projection Consensus
Suppose the current estimates of Cingulate's value are higher than the current market price of the Cingulate stock. In this case, investors may conclude that Cingulate is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cingulate's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 3 | 72.34% | -1.35 | -2.95625 | -2.77 |
Cingulate Earnings per Share Projection vs Actual
Actual Earning per Share of Cingulate refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Cingulate predict the company's earnings will be in the future. The higher the earnings per share of Cingulate, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Cingulate Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Cingulate, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Cingulate should always be considered in relation to other companies to make a more educated investment decision.Cingulate Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Cingulate's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-13 | 2025-09-30 | -0.95 | -1.35 | -0.4 | 42 | ||
2025-08-19 | 2025-06-30 | -0.93 | -2.14 | -1.21 | 130 | ||
2025-05-08 | 2025-03-31 | -0.94 | -1.04 | -0.1 | 10 | ||
2025-03-27 | 2024-12-31 | -2.93 | -3.68 | -0.75 | 25 | ||
2024-11-11 | 2024-09-30 | -2.22 | -1.83 | 0.39 | 17 | ||
2024-08-13 | 2024-06-30 | -4.92 | -5.47 | -0.55 | 11 | ||
2024-05-08 | 2024-03-31 | -12.48 | -7.2 | 5.28 | 42 | ||
2024-03-31 | 2023-12-31 | -4.86 | -7.66 | -2.8 | 57 | ||
2023-11-13 | 2023-09-30 | -0.37 | -0.3 | 0.07 | 18 | ||
2023-08-14 | 2023-06-30 | -0.35 | -0.57 | -0.22 | 62 | ||
2023-05-10 | 2023-03-31 | -0.34 | -0.35 | -0.01 | 2 | ||
2023-03-10 | 2022-12-31 | -0.37 | -0.41 | -0.04 | 10 | ||
2022-11-14 | 2022-09-30 | -0.37 | -0.36 | 0.01 | 2 | ||
2022-08-11 | 2022-06-30 | -0.58 | -0.36 | 0.22 | 37 | ||
2022-05-12 | 2022-03-31 | -0.23 | -0.44 | -0.21 | 91 | ||
2022-03-10 | 2021-12-31 | -0.39 | -0.32 | 0.07 | 17 | ||
2021-12-09 | 2021-09-30 | 0 | -1.38 | -1.38 | 0 | ||
2021-09-27 | 2021-06-30 | 0 | -0.35 | -0.35 | 0 |
About Cingulate Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Cingulate earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Cingulate estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Cingulate fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -97.6 M | -102.5 M | |
| Earnings Yield | (0.95) | (0.90) | |
| Price Earnings Ratio | (1.09) | (1.14) | |
| Price Earnings To Growth Ratio | 0.01 | 0.01 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Can Biotechnology industry sustain growth momentum? Does Cingulate have expansion opportunities? Factors like these will boost the valuation of Cingulate. Projected growth potential of Cingulate fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Cingulate demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding Cingulate requires distinguishing between market price and book value, where the latter reflects Cingulate's accounting equity. The concept of intrinsic value - what Cingulate's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push Cingulate's price substantially above or below its fundamental value.
It's important to distinguish between Cingulate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cingulate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Cingulate's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.